Integrative analysis identifies structural and regulatory changes that enhance resistance to witches' broom disease in cupuassu, suggesting new avenues for breeding.
Cupuassu ( Theobroma grandiflorum) is a fruit tree native to the Brazilian Amazon, increasingly integrated into regional bioeconomies. Its cultivation is severely threatened by the witches' broom disease (WBD), caused by Moniliophthora perniciosa. A telomere-to-telomere (T2T) genome is available for the WBD-susceptible genotype C1074; however, the lack of a resistant reference has hindered a detailed understanding of the mechanistic basis of host resistance. Here, we present the first T2T assembly of the resistant genotype C174 (415.8 Mb) and a comparative analysis with C1074, which integrates structural variant detection, gene duplication profiling, transposable element (TE) analysis, and time-resolved host–pathogen transcriptomics. C174 displays distinctive tandem and dispersed duplications, lineage-specific TE insertions, and phased defense-gene expression, together with higher heterozygosity that suggests broader allelic diversity. Although C1074 encodes more NLR receptors (541 vs. 434), most are transcriptionally silent; by contrast, C174 shows sequential induction of pattern-recognition receptors, MAP-kinase components, diverse transcription factors, and pathogenesis-related proteins. Within the major WBD-resistance QTL, localized on chromosome 6, we identified two duplicated DUF4220/ DUF594 genes unique to C174 that are induced after infection and exhibit episodic positive selection, consistent with recent neofunctionalization. Genome-wide, TEs are differentially expressed and colocalized with immune loci in a genotype-specific manner, indicating TE-associated regulatory variation. Collectively, these results suggest that structural, duplicative, and regulatory innovations—rather than simple gene-count expansion—shape WBD resistance in cupuassu. The C174 T2T assembly, immune-related variants catalogue, and DUF4220/ DUF594 candidates constitute a valuable resource for molecular breeding, genome editing, and the sustainable improvement of this tropical perennial crop.
No takes yet. Share an insight, caveat, or question.
Abreu et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: